StockNews.AISignal intelligence
Company intelligence

ENTX

Entera Bio Ltd. · NASDAQ · Healthcare

Price$3.03+0.17% · +$0.01
Market cap526.77MEquity value
P / E-8.6Trailing ratio
Volume85.91KLatest session
Market data

ENTX price chart

TradingView
Related signals
1 min delayed

Browse public ENTX signals with their source context and measured market impact. Open any signal for its permanent analysis page.

ENTXJul 29, 2026-8.10% since signal

Entera Bio secures financing to extend runway and advance EB613 toward FDA

Entera Bio announced a financing package to extend its cash runway to 2030 and fund EB613’s Phase 3 toward an FDA filing. The plan includes roughly 122.96 million ordinary shares and up to 11.84 million pre-funded warrants priced at $2.04, led by BVF Partners, who will gain two board seats. While the deal improves liquidity and optionality, it raises dilution concerns and leaves near-term price action vulnerable to earnings and market momentum.

View signal analysis
Research

Company intelligence